| 发布于: | Android | 转发：0 | 回复：0 | 喜欢：0 |
$Summit Therapeutics(SMMT)$
Citigroup Maintains Buy on Summit Therapeutics, Raises Price Target to $13
花旗集团维持对Summit Therapeutics的买入，将目标股价上调至13美元
Citigroup analyst Yigal Nochomovitz maintains Summit Therapeutics (NASDAQ:SMMT) with a Buy and r...